Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant oxaliplatin + 5-fluorouracil + calcium folinate after liver transplantation for hepatocellular carcinoma beyond Milan criteria
ChiCTR-TRC-10000961Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jan 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxaliplatin, fluorouracil and folinic acid in hepatocellular carcinoma (HCC) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Survival duration, Time to recurrence and 2 more. Started Jan 2005; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000961.